GNFT: Commercial success in PBC, diagnostic advances in MASH, and a strong pipeline drive future growth
Strong financials and strategic partnerships support robust growth, with Iqirvo achieving significant commercial milestones and expanded market potential in PBC and PSC. Diagnostic innovation in MASH is validated by guidelines and Medicare coverage, while a diversified clinical pipeline targets hig…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.